Literature DB >> 26776763

Association between dental amalgam fillings and Alzheimer's disease.

Amin Zarghami1, Seyyed Mohammad Masoud Hojjati2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26776763      PMCID: PMC4716642          DOI: 10.1186/s13195-016-0175-0

Source DB:  PubMed          Journal:  Alzheimers Res Ther            Impact factor:   6.982


× No keyword cloud information.
Sun et al. [1] evaluated the association between dental amalgam fillings and Alzheimer’s disease (AD) in a large scale Taiwanese population aged 65 years and older in a cross-sectional study and concluded that women’s exposure to amalgam was significantly associated with AD. Their findings, as the first data from a population-based study, are valuable while a previous retrospective cohort study in New Zealand could not investigate the association between dental amalgam exposure and AD due to insufficient cases [2]. In comparison with previous studies which indicated higher mercury concentrations in serum and cerebrospinal fluid samples of living and brain samples of deceased patients with Alzheimer’s disease [3, 4], Sun et al. exclusively assessed epidemiologic variables based on the Longitudinal Health Insurance Database. Several aspects of the results of their study need to be interpreted with caution due to their cross-sectional study design, and multiple limitations affected the power of study. Firstly, the duration of National Health Insurance (NHI) coverage since 2001 would include patients in their sixth and seventh decades but the pathophysiology of AD may have started much earlier. On the other hand, they mention that actual fillings were underestimated during the patients’ life-times but this fact also existed for non-AD participants because most of the dental preservation procedures were performed during their youth to middle age. Although they considered multiple face amalgam restorations based on the different NHI codes, they did not differentiate between single and multiple fillings and unfortunately there was no specific analysis of whether there is a difference between single versus multiple-surface amalgam restoration or not. On the other hand, based on their findings, what is the current interpretation for sex differences with regard to amalgam-associated AD? Are females more affected by this agent or not? Altogether, they describe well their limitations in such an epidemiological study but, according to what they found, future investigations are needed to definitively explore the association between AD and amalgam by evaluating the duration of exposure to amalgam, considering the number of dental fillings, the size of restorations and the covering surface area and other probable risk factors that play roles in the pathophysiology of AD.
  4 in total

Review 1.  Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.

Authors:  Joachim Mutter; Johannes Naumann; Catharina Sadaghiani; Rainer Schneider; Harald Walach
Journal:  Neuro Endocrinol Lett       Date:  2004-10       Impact factor: 0.765

2.  Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.

Authors:  Lars Gerhardsson; Kaj Blennow; Thomas Lundh; Elisabet Londos; Lennart Minthon
Journal:  Dement Geriatr Cogn Disord       Date:  2009-08-12       Impact factor: 2.959

3.  Health effects of dental amalgam exposure: a retrospective cohort study.

Authors:  Michael N Bates; Jackie Fawcett; Nick Garrett; Terry Cutress; Tord Kjellstrom
Journal:  Int J Epidemiol       Date:  2004-05-20       Impact factor: 7.196

4.  Association between dental amalgam fillings and Alzheimer's disease: a population-based cross-sectional study in Taiwan.

Authors:  Yi-Hua Sun; Oswald Ndi Nfor; Jing-Yang Huang; Yung-Po Liaw
Journal:  Alzheimers Res Ther       Date:  2015-11-12       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.